Tcm Associates, Ltd.
United KingdomFDA applicant, unverified
- Devices
- 1
What Tcm Associates, Ltd. makes
Tcm Associates, Ltd. manufactures GranOSTM, a synthetic bone graft substitute composed of beta tricalcium phosphate granules used for bone regeneration in surgical procedures.
GranOSTM is classified as a Class II medical device and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
- Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Tcm Associates, Ltd. have in the registry?
The registry currently lists 1 device for Tcm Associates, Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Tcm Associates, Ltd.'s devices?
Among its 1 most recently registered device, Tcm Associates, Ltd. has devices listed in FDA 510(k) (1 device).
What risk classes do Tcm Associates, Ltd.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Tcm Associates, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Tcm Associates, Ltd. in the registry?
The most recently registered devices listed for Tcm Associates, Ltd. include GranOSTM - beta tricalcium phosphate synthetic bone granules.